The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Frontier Smart Technologies Grp Ltd

23 Aug 2019 12:31

RNS Number : 1007K
Science Group PLC
23 August 2019
 

 

23 August 2019 

Science Group plc

(the "Company" or "Science Group")

 

Investment in Frontier Smart Technologies Group Limited ("Frontier")

 

Further to the announcement by Frontier on 21 August 2019, the Company confirms that it has now entered into the Subscription Agreement and the Standby Facility referred to in that announcement.

 

Under the Subscription Agreement Science Group has conditionally subscribed £1 million for 4 million new Frontier ordinary shares. Following Admission, Science Group's shareholding in Frontier will be 23,447,431 ordinary shares, equivalent to 52.3% of the voting share capital.

 

Frontier's net assets will be consolidated into the accounts of Science Group. In the year ended 31 December 2018 Frontier made a loss before taxation of $3.3 million and had gross assets at 31 December 2018 of $33.9 million. Following Admission, the total consideration paid by Science Group for 23,447,431 ordinary shares in Frontier is £6.9 million.

 

The Standby Facility will expire on 30 April 2022 and will be on broadly the same terms and conditions as the Bank facility, save that, reflecting the current circumstances of Frontier:

 

(i) it is structured as a term loan rather than revolving credit facility;

(ii) the interest rate on drawn amounts will be 12% above 3 month LIBOR;

(iii) Science Group has agreed that the first covenant test date will be March 2020; and

(iv) any amount drawn will be convertible, at Science Group's sole discretion, into new Frontier shares at 25 pence per share at any time on or after 1 January 2020.

 

If not drawn, either fully or in part, by 30 April 2021, the Standby Facility will be withdrawn.

 

 

- Ends -

 

For further information:

Science Group

Martyn Ratcliffe

Rebecca Archer

Sarah Cole

 

 

Tel: +44 (0) 1223 875 200

Panmure Gordon (Financial Adviser, Nominated Adviser and Broker to Science Group)

Dominic Morley / Alina Vaskina (Corporate Finance)

Erik Anderson (Corporate Broking)

 

 

Tel: +44 (0) 20 7886 2500

 

The information contained within this announcement is considered by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURZMGZRMFKGLZM
Date   Source Headline
20th Feb 201210:16 amRNSHolding(s) in Company
16th Feb 20127:00 amRNSCompletion of placing
13th Feb 20127:00 amRNSPlacing raises £11.2m
13th Feb 20127:00 amRNSTrading update
3rd Jan 20127:00 amRNSSubsidiary established with Imagination Technologi
24th Oct 20117:00 amRNSTelran distribution clearance
21st Sep 20117:00 amRNSHalf year results
9th Aug 20114:52 pmRNSNotice of Results
29th Jul 20117:00 amRNSHalf year trading update
11th Jul 20117:00 amRNSFDA approval for Sensium
11th Jul 20117:00 amRNSJV established with CCE
5th May 20115:24 pmRNSResult of AGM
29th Mar 20117:00 amRNSFull year results
16th Mar 20113:16 pmRNSNotice of Results
16th Mar 20113:05 pmRNSHolding(s) in Company
3rd Mar 20114:34 pmRNSIssue of Equity
2nd Mar 20118:14 amRNS£1.8m Raised
10th Feb 20117:41 amRNSStrategic Investment
1st Feb 20117:00 amRNSTELRAN Launch
1st Feb 20117:00 amRNSYear End Trading Update
30th Nov 20107:00 amRNSXENIF processor in production
15th Sep 20107:00 amRNSInterim Results
24th Aug 20109:33 amRNSIssue of Equity
11th Aug 201011:52 amRNSNotice of Results
27th Jul 20107:00 amRNSLicense agreement
15th Jul 201010:19 amRNSIssue of Equity and Exercise of Options
30th Jun 20107:00 amRNSTrading Update
16th Jun 20108:49 amRNSAnnual Financial Report
26th May 20109:07 amRNSChange of Name
10th May 20102:52 pmRNSResult of AGM
30th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSQuanta takes strategic stake
11th Mar 20104:27 pmRNSDirector dealings
10th Mar 201011:26 amRNSNotice of Results
23rd Feb 20107:00 amRNSClinical Trial Update
1st Feb 20102:02 pmRNSExercise of Options - replacement
29th Jan 201012:33 pmRNSExercise of Options
22nd Dec 200911:19 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSHolding(s) in Company
17th Dec 20093:10 pmPRNResult of EGM
14th Dec 20093:34 pmPRNDirector/PDMR Shareholding
1st Dec 20097:00 amPRNProposed Placing and Update
9th Nov 20091:20 pmRNSNational Microelectronics Institute Award
2nd Nov 20097:00 amPRNSensium Digital Plaster European Trial
28th Sep 20097:00 amPRNHalf-yearly Report
22nd Sep 200912:16 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSCorrection re holding in company
10th Sep 20097:00 amRNSHolding(s) in Company
7th Aug 200912:01 pmRNSHolding(s) in Company
22nd Jul 200911:21 amPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.